Paid Clinical Trials in Hinsdale, IL
As of August 2026, 52 paid clinical trials are recruiting in Hinsdale, Illinois. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Hinsdale offers studies at sites including Hope and Healing Cancer Services for conditions such as Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-small Cell Lung Cancer, Anatomic Stage I Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Hinsdale
Trials by drug in Hinsdale
Filter results
52 clinical trials
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
GEMINI-NSCLC: NSCLC Biomarker Study
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Caris Biorepository Research Protocol
Prospective Study to Assess a Diagnostic Aid for Cancer
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
Study of WAL0921 in Patients With Glomerular Kidney Diseases
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Top Research Study Locations in Hinsdale
Researchers run research studies in Hinsdale, IL at 18 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Hope and Healing Cancer Services | Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung | 21 |
| UChicago Medicine AdventHealth Cancer Institute Hinsdale | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 4 |
| Hope And Healing Care | Early Breast Cancer, Primary Evans Syndrome (ES), Primary Immune Thrombocytopenia (ITP) | 2 |
| Hope and Healing Clinical Research | Lung Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung (NSCLC) | 2 |
| Hope and Healing Clinical Research LLC | Advanced Solid Tumors, Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma | 2 |
| RML Specialty Hospital | Candida Auris Infection, Colonization, Asymptomatic, Multi-Drug Resistant Organism Colonization | 2 |
| AMITA Health Adventist Medical Center Hinsdale | Lumbar Spinal Stenosis | 1 |
| Dr. Sudarshan K. Sharma, Ltd. | Endometrial Cancer | 1 |
| Hinsdale Surgical Center | Lumbar Spinal Stenosis | 1 |
| Investigational | Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion | 1 |
| NANI Research | Primary Membranous Nephropathy | 1 |
| Nephrology Associates of Northern Illinois and Indiana (NANI) | Diabetic Nephropathies, Minimal Change Disease, Primary Focal Segmental Glomerulosclerosis | 1 |
| Orthopaedic Spine Institute | Degenerative Lumbar Disc Disease, Radiculopathy Lumbar | 1 |
| Rush University Medical Center | ASCVD, Type2Diabetes | 1 |
| UChicago Medicine Advent Hinsdale | to Determine Whether Patient Satisfaction With Postoperative Telehealth Follow-up is Non-inferior to In-person Clinic Visits | 1 |
| UChicago Medicine AdventHealth Hinsdale | Perinatal Decision Making | 1 |
| University of Chicago | Heart Failure - NYHA II - IV | 1 |
| University of Illinois Health/ University of Illinois at Chicago | Chronic Pain, Opioid-use Disorder | 1 |
Active & Upcoming Studies in Hinsdale (2026)
Recruiting trials in Hinsdale grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (30 active studies)
- Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer · Phase 2 · Pfizer
- Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC · Phase 2 · Pfizer
Diabetes & metabolic (1 active study)
Neurology & pain (1 active study)
- Optimization of NIBS for Treatment of Addiction · Case Western Reserve University
Cardiovascular (1 active study)
Common conditions studied in Hinsdale
- Non-Small Cell Lung Cancer (5 active studies)
- Cancer (3 active studies)
- Carcinoma, Non-Small-Cell Lung (NSCLC) (3 active studies)
- Non-small Cell Lung Cancer (3 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
Leading research sponsors in Hinsdale
- AstraZeneca
- Pfizer
- AbbVie
- BeOne Medicines
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Hinsdale?
There are approximately 52 recruiting clinical trials in Hinsdale, Illinois listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Hinsdale pay participants?
Most recruiting trials in Hinsdale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Hinsdale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Hinsdale?
The most common conditions under active study in Hinsdale include Non-Small Cell Lung Cancer (5), Cancer (3), Carcinoma, Non-Small-Cell Lung (NSCLC) (3), Non-small Cell Lung Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Hinsdale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hinsdale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Hinsdale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Hinsdale?
Recruiting research sites in Hinsdale include Hope and Healing Cancer Services, UChicago Medicine AdventHealth Cancer Institute Hinsdale, Hope And Healing Care, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Hinsdale right now?
The largest active categories in Hinsdale are Cancer & tumors (30), Diabetes & metabolic (1), Neurology & pain (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.